Publication Date: 2022/07/09
Abstract: The vaxzevria is a vaccine for preventing covid19 caused by SARS-CoV-2 virus in people from the age of 18 years and older. Also known as Astra-Zeneca or (ChAdOx1 S [recombinant]). The vaccine is 63% effective in an ongoing, large-scale clinical trial. The vaccine has been modified to induce either of mRNA COVID-19 vaccines (Pfizer or Moderna). They can be used as a second dose in cases where Astra Zeneca was given as the first dose. Though the vaccine has been approved in nearly 138 countries, a total of 184,679 cases of side effects were reported. The vaccine has reported to prevent over 50 million COVID-19 cases. The vaccine is taken as 2 doses plus a booster dose of injections.
Keywords: Astra-Zeneca; AZD1222; Covid -19; Delta Variant; Side Effects; TTS
DOI: https://doi.org/10.5281/zenodo.6812559
PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT22JUN1193.pdf
REFERENCES